Cardiac surgery has an inherently high risk of perioperative bleeding.
The increasing use of anti-thrombotics, poses a significant additional risk of bleeding if drug washout is not possible due to urgency. CytoSorb® therapy is safe and effective for intraoperative antithrombotic drug removal.
Infective endocarditis (IE) surgical patients can suffer from high rates of severe complications leading to high mortality.
CytoSorb® therapy safely and effectively reduces excessive cytokine levels in IE patients.
Do you want to learn more?